OMB APPROVAL
       
 OMB Number:3235-0167
   
UNITED STATES
 
 Expires:November 30, 2010
   
SECURITIES AND EXCHANGE COMMISSION
 
 Estimated average burden
   
Washington, D.C. 20549
 
 hours per response        1.50    


FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number      000-53145            
 
 
Patient Portal Technologies, Inc.
(Exact name of registrant as specified in its charter)
 
8276 Willett Parkway, Suite 200, Baldwinsville, New York 13027    Phone: (315) 638-6708
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Common Stock, $.001 Par Value
(Title of each class of securities covered by this Form)
 
N/A
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 
Rule 12g-4(a)(1)
 
x
 
Rule 12g-4(a)(2)
 
o
 
Rule 12h-3(b)(1)(i)
 
x
 
Rule 12h-3(b)(1)(ii)
 
o
 
Rule 15d-6
 
o

Approximate number of holders of record as of the certification or notice date:    170             

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 

Date:   October 12, 2010           
By: Kevin Kelly, Chief Executive Officer

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
 

 
Persons who respond to the collection of information contained
 
 
in this form are not required to respond unless the form displays
 
SEC2069(02-08)
a currently valid OMB control number.
 
 
 

Patient Portal Technolog... (CE) (USOTC:PPRG)
過去 株価チャート
から 11 2024 まで 12 2024 Patient Portal Technolog... (CE)のチャートをもっと見るにはこちらをクリック
Patient Portal Technolog... (CE) (USOTC:PPRG)
過去 株価チャート
から 12 2023 まで 12 2024 Patient Portal Technolog... (CE)のチャートをもっと見るにはこちらをクリック